tag:blogger.com,1999:blog-156164852011-12-14T18:40:54.789-08:00jenenoreply@blogger.comBlogger7191100tag:blogger.com,1999:blog-15616485.post-1125691751075619282005-09-02T13:09:00.000-07:002005-09-02T13:09:11.093-07:00

NewsMakers in the Biotech Industry Conference to Webcast Millennium Presentation CAMBRIDGE, Mass., Sept. 2 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (NASDAQ:MLNM) today announced that its presentation at the NewsMakers in the Biotech Industry Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com/.

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125690571755531082005-09-02T12:49:00.000-07:002005-09-02T12:49:31.773-07:00

America's Pharmaceutical Companies Increase Relief Efforts; Nearly $25 Million in Medicines, Cash Donated So Far WASHINGTON, Sept. 2 /PRNewswire/ -- America's pharmaceutical research companies continue to send comprehensive disaster aid packages to public and private relief organizations to help lessen the suffering of survivors and to stem a looming public health crisis in the Gulf Coast region

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125689760105712252005-09-02T12:36:00.000-07:002005-09-02T12:36:00.120-07:00

CVS/pharmacy Deploys Additional Pharmacy Resources to Hurricane-Impacted Gulf CoastCVS Lines Up 30 Mobile Pharmacy Units to be Deployed in the Impacted Area -- First Unit Set Up Today at Houston AstrodomeBaton Rouge Stores Converted to Round-the-Clock Service WOONSOCKET, R.I., Sept. 2 /PRNewswire-FirstCall/ -- CVS/pharmacy announced today that it is continuing to deploy emergency pharmacy

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125687362021272482005-09-02T11:56:00.000-07:002005-09-02T11:56:02.036-07:00

Nu Skin Enterprises Opens Walk-in Center in Greater NagoyaFacility Will Support Growth in the Market and Further Increase Company's Profile in Japan PROVO, Utah, Sept. 2 /PRNewswire-FirstCall/ -- Nu Skin Enterprises (NYSE:NUS) today announced the opening of a new distributor walk-in center in Greater Nagoya that will support increased growth of the company's business in the region. Greater Nagoya

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125686481834936142005-09-02T11:41:00.000-07:002005-09-02T11:41:21.836-07:00

Dionex Corporation to Present at the Thomas Weisel Partners Growth Forum 7.0 SUNNYVALE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Dionex Corporation (NASDAQ:DNEX) announced today that it will present at the Thomas Weisel Partners Growth Forum 7.0 on Thursday, September 8, 2005 at 3:50 p.m. (Eastern Time).Dr. Lukas Braunschweiler, President and Chief Executive Officer, will give an overview of the

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125685999922870212005-09-02T11:33:00.000-07:002005-09-02T11:33:19.933-07:00

SeraCare Life Sciences, Inc. to Present at Thomas Weisel Partners Healthcare Conference 2005 OCEANSIDE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- SeraCare Life Sciences, Inc. (NASDAQ:SRLS) today announced that it is scheduled to give an investor presentation at the Thomas Weisel Partners Healthcare Conference on September 7, 2005.SeraCare Chairman, Barry Plost, and CEO, Mike Crowley, will be

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125685744741501052005-09-02T11:29:00.000-07:002005-09-02T11:29:04.756-07:00

American Red Cross Announces Family Linking Available Via www.redcross.org WASHINGTON, Sept. 2 /PRNewswire/ -- The American Red Cross, with support of the worldwide Red Cross and Red Crescent Movement, is launching a Web site to help assist family members who are seeking news about loved ones living in the path of Hurricane Katrina. Visit the "Family Links Registry" via http://www.redcross.org/

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125684883468300792005-09-02T11:14:00.000-07:002005-09-02T11:14:43.483-07:00

Quest Diagnostics To Aid Hurricane Relief Efforts LYNDHURST, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE:DGX), the nation's leading provider of diagnostic testing, information and services, announced efforts to assist victims of Hurricane Katrina.The company has pledged $50,000 to the American Red Cross Hurricane 2005 Relief Fund. In addition, Quest Diagnostics

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125684435348938802005-09-02T11:07:00.000-07:002005-09-02T11:07:15.360-07:00

Carrington Donates Medical Supplies to Hurricane Victims Through Congressman Pete Sessions' InitiativeSpecial Program Developed for Additional Requests for Aid IRVING, Texas, Sept. 2 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (NASDAQ:CARN) today announced it has donated medical supplies in support of Congressman Pete Sessions' (R-TX 32nd) initiative to provide immediate aid to the

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125684156455120072005-09-02T11:02:00.000-07:002005-09-02T11:02:36.456-07:00

Immunomedics Announces Change in Senior Management MORRIS PLAINS, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Immunomedics, Inc. (NASDAQ:IMMU) today announced Ivan Horak, M.D., the Company's Executive Vice President of Research and Development and Chief Scientific Officer, has terminated his employment with the Company. Dr. Horak has decided to refocus his career in oncology and the development of

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125683869992624742005-09-02T10:57:00.000-07:002005-09-02T10:57:50.010-07:00

Adult Stem Cells From Adipose Tissue Could Save LivesScientists to Present Findings at National Meeting CHARLOTTESVILLE, Va., Sept. 2 /PRNewswire/ -- National and international scientists, including those from the University of Virginia Health System, will announce findings from a significant number of studies showing that adult stem cells from adipose tissue (fat) could eventually be used to

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125683655772496252005-09-02T10:54:00.000-07:002005-09-02T10:54:15.786-07:00

AHIP Launches Web Site Providing Health Plan Policy Updates for Victims of Hurricane KatrinaMany Health Insurance Plans are Updating their Policies to Provide Relief to Victims of this Disaster WASHINGTON, Sept. 2 /PRNewswire/ -- America's Health Insurance Plans (AHIP) and its members are working together to provide support to those affected by Hurricane Katrina. In response to this disaster,

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125683025574456602005-09-02T10:43:00.000-07:002005-09-02T10:43:45.586-07:00

Global Rapid Response Supports Stability and Recovery Efforts in New OrleansPrivate Security and Crisis Managers Support New Orleans SAN FRANCISCO, Sept. 2 /PRNewswire/ -- Global Rapid Response(TM), a Steele Foundation service, has mobilized a Crisis Response Team to support those trapped in New Orleans and neighboring cities and states to assist clients in the recovery efforts of Hurricane

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125682823232100222005-09-02T10:40:00.001-07:002005-09-02T10:40:23.233-07:00

AtriCure Announces Web Cast and Conference Call of Second Quarter 2005 Results WEST CHESTER, Ohio, Sept. 2 /PRNewswire-FirstCall/ -- AtriCure, Inc. (NASDAQ:ATRC), a medical device company focused on developing, manufacturing and selling innovative surgical devices, will release its financial results for the quarter ended June 30, 2005 on Friday, September 9, 2005 before the opening of the U.S.

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125682804988042172005-09-02T10:40:00.000-07:002005-09-02T10:40:05.003-07:00

Merck Commits $1 Million to Disaster Relief Fund in Wake of Hurricane Katrina WASHINGTON, Sept. 2 /PRNewswire/ -- Merck announced a contribution of $1 million to the American Red Cross Disaster Relief Fund to assist in relief efforts for victims of Hurricane Katrina. Merck will also match employee contributions to the American Red Cross."Our thoughts are with all of the people in the Gulf Coast

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125682050533303902005-09-02T10:27:00.000-07:002005-09-02T10:27:30.536-07:00

Epilepsy Foundation Issues Emergency Information for Hurricane Refugees Experiencing Seizures LANDOVER, Md., Sept. 2 /PRNewswire/ -- Following a series of recent news reports from the afflicted Gulf Coast, the Epilepsy Foundation today recommended the following steps for people with epilepsy requiring daily medication to prevent seizures and who have been dislocated from areas hard- hit by

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125681972361285862005-09-02T10:26:00.000-07:002005-09-02T10:26:12.373-07:00

AtriCure to Present at Thomas Weisel Partners Healthcare Tailwinds 2005 Conference WEST CHESTER, Ohio, Sept. 2 /PRNewswire-FirstCall/ -- AtriCure, Inc. (NASDAQ:ATRC), a medical device company focused on developing, manufacturing and selling innovative surgical devices, announced today that management is scheduled to present at the Thomas Weisel Partners Healthcare Tailwinds 2005 Conference at The

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125681818227910622005-09-02T10:23:00.000-07:002005-09-02T10:23:38.243-07:00

VisEn Medical Announces the Launch of an Industry-First FMT Imaging System and Optical Probe Product LineBacked by 18 Abstracts at the 4th Annual Meeting of the Society For Molecular Imaging CAMBRIDGE, Mass., Sept. 2 /PRNewswire/ -- VisEn Medical today announced that it will formally launch its Fluorescence Molecular Tomography ("FMT") system and optical probe product line at the Fourth Annual

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125679919995169572005-09-02T09:51:00.000-07:002005-09-02T09:52:00.013-07:00

Longs Drug Stores Offers a Matching Contribution Program to Support American Red Cross Hurricane Relief Efforts WALNUT CREEK, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Longs Drug Stores Corporation (NYSE:LDG) today announced a fundraising program to support the relief efforts for victims of Hurricane Katrina.Longs is offering $1, $5, $10 and $25 relief certificates at all of its stores as a

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125678317492571592005-09-02T09:25:00.000-07:002005-09-02T09:25:17.506-07:00

Kaiser Permanente Contributes $2 Million to Support Public Health Response to KatrinaThe CDC Foundation Seeks Donations to Help CDC and Public Health Partners Purchase Critical Supplies and Equipment ATLANTA, Sept. 2 /PRNewswire/ -- The CDC Foundation today announced a $2 million gift from Kaiser Permanente to support the national public health response to Hurricane Katrina. The contribution was

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125677468920992192005-09-02T09:11:00.000-07:002005-09-02T09:11:08.920-07:00

Conference Call Notice - MIGENIX First Quarter Fiscal 2006 Financial Results Conference Call & Web Cast NotificationWednesday, September 7, 2005 - 11:00 a.m. ET; 8:00 a.m. PT VANCOUVER and SAN DIEGO, CA, Sept. 2 /PRNewswire-FirstCall/ -- MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious and degenerative diseases, will host a conference call and web cast on

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125676996104482312005-09-02T09:03:00.000-07:002005-09-02T09:03:16.116-07:00

Varian, Inc. CFO to Speak at Thomas Weisel Partners Healthcare Tailwinds 2005 Conference PALO ALTO, Calif., Sept. 2 /PRNewswire-FirstCall/ -- G. Edward McClammy, Senior Vice President, Chief Financial Officer and Treasurer, Varian, Inc. (NASDAQ:VARI) will be speaking at the Thomas Weisel Partners Healthcare Tailwinds 2005 Conference in Boston, Massachusetts on Friday, September 9 at 11:35 a.m.

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125676970622192992005-09-02T09:02:00.000-07:002005-09-02T09:02:50.636-07:00

HACC Dedicates New Select Medical Health Education Pavilion Sept. 7 Who: Representatives from HACC, including President Edna V. Baehre, Ed.D., Select Medical CEO Robert Ortenzio and Pennsylvania Senator Pat Vance along with Capital Campaign co-chairs Donald Schell and Governor George M. Leader will formally dedicate the new allied

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125676349546520442005-09-02T08:52:00.000-07:002005-09-02T08:52:29.560-07:00

Tanox to Present at Bear Stearns Health Care Conference HOUSTON, Sept. 2 /PRNewswire-FirstCall/ -- Tanox, Inc. (NASDAQ:TNOX) will deliver a presentation at the 18th annual Bear Stearns Health Care Conference Sept. 12 and 13, 2005 in New York City.Tanox Vice President of Finance Greg Guidroz and Medical Director Dr. Stanley Lewis are scheduled to present Sept. 13 at 4 p.m. EDT. Guidroz and Lewis

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125673409824921792005-09-02T08:03:00.001-07:002005-09-02T08:03:29.840-07:00

Affymax Announces Participation in Upcoming Conferences PALO ALTO, Calif., Sept. 2 /PRNewswire/ -- Affymax, Inc., a privately held development stage pharmaceutical company, today announced that Arlene M. Morris, the company's president and chief executive officer, will present at three upcoming conferences in September:Thomas Weisel Partners' Healthcare Conference 2005 on Wednesday,September 7,

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125673403338696332005-09-02T08:03:00.000-07:002005-09-02T08:03:23.353-07:00

Affymax Announces Participation in Upcoming Conferences PALO ALTO, Calif., Sept. 2 /PRNewswire/ -- Affymax, Inc., a privately held development stage pharmaceutical company, today announced that Arlene M. Morris, the company's president and chief executive officer, will present at three upcoming conferences in September: Thomas Weisel Partners' Healthcare Conference 2005 on Wednesday,

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125672523765887182005-09-02T07:48:00.000-07:002005-09-02T07:48:43.780-07:00

SkyePharma Announces Date of Release of Interim Results For The Six Months Ending 30 June 2005Update On Flutiform(TM) Negotiations LONDON, Sept. 2 /PRNewswire-FirstCall/ -- SkyePharma PLC will announce its Interim results for the six months ending 30 June 2005 on Wednesday 28 September 2005. These results will be the first presented under International Financial Reporting Standards.SkyePharma

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125671544788227082005-09-02T07:32:00.000-07:002005-09-02T07:32:24.803-07:00

Medicare Writing Up Improved PrescriptionChoices are up and costs are down. So says the Medicare agency about its new prescription drug benefit, which begins in January.The drug coverage will cost less than originally expected, according to the Centers for Medicare & Medicaid Services. The average premium has fallen to $32.20, down from $37. In every state except Alaska, there will be at least

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125670208077345252005-09-02T07:10:00.000-07:002005-09-02T07:10:08.076-07:00

BIO 2006 in Chicago, April 9-12, 2006 Memorandum TO: Editors and Reporters Covering Biotechnology FROM: Dan Eramian, VP Communications, BIO DATE: Sept. 2, 2005 RE: BIO 2006 in Chicago, April 9-12, 2006As you plan travel for the upcoming year, we'd like to remind you that the Biotechnology Industry Organization's BIO 2006 Annual International Convention will be taking place April

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125669710536933812005-09-02T07:01:00.000-07:002005-09-02T07:01:50.536-07:00

MedQuist Selects VoiceGard for Voice Disaster Recovery Services- Client Service Will Continue Without Interruptions During an Emergency - MOUNT LAUREL, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Today, MedQuist (Pink Sheets: MEDQ) announced a contract with VoiceGard, the leader in developing and implementing business solutions for today's business communication recovery needs, to help provide

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125669301393758732005-09-02T06:55:00.000-07:002005-09-02T06:55:01.406-07:00

Johnson & Johnson Advised by Canadian Competition Bureau on Proposed Acquisition of Guidant Corporation NEW BRUNSWICK, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Johnson & Johnson has been advised by the Canadian Competition Bureau that it has decided not to take any action at this time on the Company's proposed acquisition of Guidant Corporation in relation to markets affected by that proposed

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125666406463911692005-09-02T06:06:00.000-07:002005-09-02T06:06:46.476-07:00

Dispute Concluded with Centre Insurance Company EATONTOWN, N.J., Sept. 2 /PRNewswire-FirstCall/ -- QMed, Inc., (NASDAQ:QMED) today announced that HeartMasters LLC, a limited liability company in which QMed's IHMC subsidiary is a member, together with The Regence Group, entered into a settlement agreement resolving their dispute with Centre Insurance Company. As a result of the resolution, QMed

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125664818676498792005-09-02T05:40:00.000-07:002005-09-02T05:40:18.690-07:00

Novogen Announces Development and Expansion of U.S. Subsidiary Companies SYDNEY, Australia and STAMFORD, Conn., Sept. 2 /PRNewswire-FirstCall/ -- Novogen Limited (NASDAQ:NVGN) today announced the expansion in the U.S. of Glycotex, Inc., its U.S. subsidiary, and the resignation of Dr. Graham Kelly from Novogen's Board of Directors in order for him to focus on the development and expansion of

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125664363242327942005-09-02T05:32:00.001-07:002005-09-02T05:32:43.243-07:00

Published Study Demonstrates Single Dose of VaxGen's Smallpox Vaccine Candidate Provides Complete Protection in Mice BRISBANE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- VaxGen, Inc. (VXGN.PK) announced today that a study published in the September 2005 issue of the Journal of Virology(1) provides data showing that a single dose of VaxGen's smallpox vaccine candidate LC16m8 provides mice with 100%

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125664343010748382005-09-02T05:32:00.000-07:002005-09-02T05:32:23.026-07:00

Western Pennsylvania Hospitals Prepare to Assist in Hurricane Aftermath WARRENDALE, Pa., Sept. 2 /PRNewswire/ -- Western Pennsylvania hospitals are joining hospitals across Pennsylvania and throughout the country in preparing to assist in the aftermath of Hurricane Katrina."Hospital Council of Western Pennsylania is working hand-in-hand with hospitals across the state to offer assistance how and

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125663436348215092005-09-02T05:17:00.001-07:002005-09-02T05:17:16.366-07:00

Nabi Biopharmaceuticals to Present at the Thomas Weisel Partners 'Healthcare Tailwinds 2005' Conference BOCA RATON, Fla., Sept. 2 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals (NASDAQ:NABI) announced today that Mark L. Smith, senior vice president, finance, treasurer and chief financial officer, will be presenting at the Thomas Weisel Partners "Healthcare Tailwinds 2005" Conference on

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125663423951552402005-09-02T05:17:00.000-07:002005-09-02T05:17:03.963-07:00

Human Genome Sciences Invites Investors to Listen to Webcast of Discussion at Thomas Weisel Partners Conference ROCKVILLE, Md., Sept. 2 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (NASDAQ:HGSI) announced today that its discussion at the Thomas Weisel Partners Healthcare Conference will be webcast and may be accessed at http://www.hgsi.com/.(Logo: http://www.newscom.com/cgi-bin/prnh/

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125663351757473592005-09-02T05:15:00.000-07:002005-09-02T05:15:51.770-07:00

MedImmune to Present at Thomas Weisel Partners Healthcare Conference 2005 GAITHERSBURG, MD, Sept. 2 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today that it will present at the Thomas Weisel Partners 2005 Healthcare Conference on Thursday, September 8, 2005, at 8:35 a.m. eastern time.The conference is being held at the Four Seasons Hotel Boston in Boston, Massachusetts.

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125662784158436772005-09-02T05:06:00.000-07:002005-09-02T05:06:24.170-07:00

BioVeris Annual Meeting of Stockholders to be Held on September 15, 2005 GAITHERSBURG, Md., Sept. 2 /PRNewswire-FirstCall/ -- BioVeris Corporation (NASDAQ:BIOV) will hold its Annual Meeting of Stockholders on Thursday, September 15, 2005 at 10:00 AM (EDT). Stockholders of record at the close of business on July 25, 2005 are entitled to vote at the Annual Meeting. A notice of the Annual Meeting

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125662758272748302005-09-02T05:05:00.000-07:002005-09-02T05:05:58.283-07:00

Walgreen Co. August Sales Increase 11.7 Percent DEERFIELD, Ill., Sept. 2 /PRNewswire-FirstCall/ -- Walgreen Co. (NYSE:WAG)(NASDAQ:WAG) had August sales of $3,564,232,000, an increase of 11.7 percent from $3,190,509,000 for the same month in 2004. Sales in comparable stores (those open at least a year) rose 7.0 percent.August pharmacy sales increased 13.0 percent, while comparable pharmacy sales

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125661649455640232005-09-02T04:47:00.000-07:002005-09-02T04:47:29.483-07:00

Senomyx to Webcast Corporate Presentation at the 12th Anniversary of the BioCentury/Thomson NewsMakers in the Biotech Industry Conference LA JOLLA, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Senomyx, Inc. (NASDAQ:SNMX) announced today that the Company's President and CEO, Kent Snyder, will present a corporate overview on Friday, September 9, 2005 at 2:50 p.m. Eastern Time (11:50 a.m. Pacific Time)

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125660244550975102005-09-02T04:24:00.000-07:002005-09-02T04:24:04.553-07:00

Domantis boekt succes in oppositieactie op patentCAMBRIDGE, Verenigd Koninkrijk en CAMBRIDGE, Massachusetts, September 2/PRNewswire/ -- - Reikwijdte van patent ingrijpend ingeperkt voor Ablynx Domantis Limited, het Domain Antibody Therapeutics-bedrijf, heeft zichmet succes verzet tegen het Europese patentnummer EP0656946, wat leidt toteen belangrijke rectificatie van de hoofdaanspraak in

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125659852836558312005-09-02T04:17:00.000-07:002005-09-02T04:17:32.850-07:00

Greater Phoenix CVB Focuses on Corporate Market for Short-Term Bookings at Expanding Convention CenterSales Division Targets State/National Corporations for Bookings Into the New Phase-One Meeting & Conference Center, Opening May, 2006 PHOENIX, Sept. 2 /PRNewswire/ -- In order to sell the maximum amount of available space during the expansion of the Phoenix Convention Center, the Greater Phoenix

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125659062119601762005-09-02T04:04:00.000-07:002005-09-02T04:04:22.133-07:00

ImmuneRegen BioSciences Forms The Coalition for CountermeasuresOrganization Forms to Advocate Public/Private Partnerships and Bridge the 'Valley of Death' SCOTTSDALE, Ariz., Sept. 2 /PRNewswire-FirstCall/ -- Research and development biopharmaceutical company ImmuneRegen BioSciences, a wholly owned subsidiary of IR BioSciences Holdings, Inc. (BULLETIN BOARD: IRBO) , announced today the launch of

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125659018340482062005-09-02T04:03:00.001-07:002005-09-02T04:03:38.340-07:00

Omnicell CEO to Present at Thomas Weisel Partners Conference MOUNTAIN VIEW, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Randall A. Lipps, chairman, president and CEO of Omnicell, Inc. (NASDAQ:OMCL), a leading provider of patient safety solutions preferred by nurses, will present at the Thomas Weisel Partners Healthcare Conference 2005 at 10:55 a.m. ET on Sept. 9, 2005 in Boston. The event will be

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125658990875779102005-09-02T04:03:00.000-07:002005-09-02T04:03:10.886-07:00

Cell Therapeutics, Inc. (CTI) Announces Resignation of Independent Auditor SEATTLE, Sept. 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ: CTIC; Nuovo Mercato) announced today that Grant Thornton resigned effective August 31, 2005 as the Company's independent auditor. There were no disagreements between CTI and Grant Thornton on any matter of accounting principles or practice,

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125658889739201582005-09-02T04:01:00.000-07:002005-09-02T04:01:29.753-07:00

Cell Therapeutics, Inc. (CTI) gibt Ausscheiden von unabhängigem Rechnungsprüfer bekanntSeattle, September 2/PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ: CTIC; Nuovo Mercato) gab heutebekannt, dass Grant Thornton mit Wirkung vom 31. August 2005 als unabhängigerRechnungsprüfer des Unternehmens gekündigt hat. Es gab zwischen CTI und GrantThornton keinerlei Unstimmigkeiten bezüglich

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125657159522818452005-09-02T03:32:00.000-07:002005-09-02T03:32:39.536-07:00

Alexion Pharmaceuticals Appoints Vikas Sinha Senior Vice President and Chief Financial Officer CHESHIRE, Conn., Sept. 2 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that it has appointed Vikas Sinha as Senior Vice President and Chief Financial Officer. Mr. Sinha joins Alexion from Bayer AG where he was most recently Vice President and Chief Financial

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125655503239337882005-09-02T03:05:00.000-07:002005-09-02T03:05:03.250-07:00

Analysis Identifies Nine Causes of Irritable Bowel Syndrome (IBS) SymptomsResearcher Has Identified Nine Distinct Causes of Irritable Bowel Syndrome Symptoms and the Cause of Diarrhea, IBS With Constipation, Heartburn, Acid Reflux, and Ulcers as Well as Other Common Gastrointestinal Complaints CINCINNATI, Sept. 2 /PRNewswire/ -- Statistical analysis of successful clinical resolutions of Irritable

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125655479626933252005-09-02T03:04:00.000-07:002005-09-02T03:04:39.640-07:00

RITA Medical to Present at the 2005 Thomas Weisel Partners Healthcare Conference FREMONT, Calif., Sept. 2 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (NASDAQ:RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it has been invited to present at the Thomas Weisel Partners Healthcare Conference, which will take place at the Four Seasons

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125650014828543932005-09-02T01:33:00.000-07:002005-09-02T01:33:34.866-07:00

Los datos del stent liberador de sirolimus Cypher(R) se presentarán en el Congreso de la Sociedad Europea de Cardiología 2005MIAMI, September 2/PRNewswire/ -- Un amplio abanico de datos clínicos acerca del uso del stent coronarioliberador de sirolimus CYPHER(R) se presentarán en el Congreso de la SociedadEuropea de Cardiología 2005 (ESC 2005) que tiene lugar en Estocolmo (Suecia)del 3 al 7 de

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125624766789143412005-09-01T18:32:00.000-07:002005-09-01T18:32:46.803-07:00

Victoire de Domantis dans une procédure d'opposition de brevetCAMBRIDGE, Grande Bretagne et CAMBRIDGE, Massachusetts, September 2/PRNewswire/ -- - La portée de la couverture du brevet d'Ablynx a été réduite de façondramatique Domantis Limited, firme thérapeutique d'anticorps à domaine humains,s'est opposée avec succès au brevet européen numéro EPOB656946, ce qui aentraîné un amendement

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125619376063198832005-09-01T17:02:00.000-07:002005-09-01T17:02:56.076-07:00

Smith & Nephew Announces Favourable Court Ruling Against Synthes MEMPHIS, Tenn., Sept. 1 /PRNewswire-FirstCall/ -- Smith & Nephew plc (NYSE:SNN), the global medical technology business, today announced that the Federal District Court for the Western District of Tennessee ruled in a decision received by the company on August 31, 2005, that the Synthes' Trochanteric Fixation Nail (TFN) and Proximal

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125616685714765142005-09-01T16:18:00.000-07:002005-09-01T16:18:05.743-07:00

Medical Nutrition USA Inc. to Hold First Conference Call to Discuss the Financial Results for Its Second Quarter Fiscal 2005 ENGELWOOD, N.J., Sept. 1 /PRNewswire-FirstCall/ -- Medical Nutrition USA Inc. (BULLETIN BOARD: MDNU) invites you to participate in a conference call with its management team to discuss the Company's results for its second quarter fiscal 2005. WHEN: Thursday,

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125616587714906242005-09-01T16:16:00.000-07:002005-09-01T16:16:27.730-07:00

Les résultats sur le stent coronarien Cypher(R) à élution de sirolimus seront présentés au Congrès de cardiologie européen ESC 2005MIAMI, September 2/PRNewswire/ -- Une palette variée de résultats cliniques concernant l'utilisation du stent coronarien CYPHER(R) à élution de sirolimus sera présentée au Congrès de cardiologie européen ESC 2005 (European Society of Cardiology Congress), qui se

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125615006857319922005-09-01T15:50:00.000-07:002005-09-01T15:50:06.870-07:00

Immucor Reports Nasdaq Notice Related to Delay in Filing Form 10-K NORCROSS, Ga., Sept. 1 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that the Company has received a Nasdaq Staff Determination letter dated August 31, 2005, indicating that due to the Company's failure to

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125612819207775412005-09-01T15:13:00.000-07:002005-09-01T15:13:39.220-07:00

First Cardiovascular Techniques Summit to Focus on Providing Interventional Training to Cardiology and Surgery Fellows and Physicians FREDERICK, Md., Sept. 1 /PRNewswire/ -- Drs. Sheldon Goldberg, Daniel McCormick, William Kussmaul, and Daniel Dadourian -- internationally recognized for their leadership in the field of interventional cardiology -- will co-chair the first annual Cardiovascular

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125611662971584402005-09-01T14:54:00.000-07:002005-09-01T14:54:22.983-07:00

Ventiv Health to Present at Investor Conferences in September SOMERSET, N.J., Sept. 1 /PRNewswire-FirstCall/ -- Ventiv Health (NASDAQ: VTIV) announced today that it has been invited to present at three investor conferences during the month of September.Roth Capital Partners NY Conference:The Roth Conference will take place September 7-8, 2005 at the Westin New York at Times Square. Ventiv joins

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125609599767635552005-09-01T14:19:00.000-07:002005-09-01T14:19:59.810-07:00

A Different Kind of Food Fight at SchoolAllergy Foundation Warns Parents and Teachers to be Aware of Food Allergies This Season WASHINGTON, Sept. 1 /PRNewswire/ -- Back-to-school season can be a relief for parents after a long summer. But for parents of children with food allergies, a return to classrooms and cafeterias can bring anxiety and fear, for a good reason: food allergy reactions cause

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125607869353429772005-09-01T13:51:00.000-07:002005-09-01T13:51:09.366-07:00

Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Tailwinds Conference SAN DIEGO, Sept. 1 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the Thomas Weisel Partners Healthcare Tailwinds Conference on September 7, 2005 at approximately 8:35 a.m. Eastern Time. The presentation is scheduled to be webcast live

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125606827466205062005-09-01T13:33:00.000-07:002005-09-01T13:33:47.466-07:00

Abgenix to Webcast Three Upcoming Conference Presentations FREMONT, Calif., Sept. 1 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) today announced that it has been invited to present at three upcoming investor conferences. Each of the presentations will be accessible through the Abgenix website. Following is the schedule of presentations: * Thomas Weisel Partners Healthcare

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125606735291095682005-09-01T13:32:00.000-07:002005-09-01T13:32:15.330-07:00

ev3 Inc. to Present at Two September Investor Healthcare ConferencesPresentation at Thomas Weisel Healthcare Conference Will Be Webcast Live at 7:35 a.m. CT on Wednesday, September 7Presentation at Bear Stearns 18th Annual Healthcare Conference Will Be Webcast Live at 2:00 p.m. CT on Monday, September 12 PLYMOUTH, Minn., Sept. 1 /PRNewswire-FirstCall/ -- ev3 Inc. (NASDAQ:EVVV), a global

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125606449501658562005-09-01T13:27:00.000-07:002005-09-01T13:27:29.513-07:00

Wyeth Announces $1 Million Donation in Support of Hurricane Katrina Relief Efforts MADISON, N.J., Sept. 1 /PRNewswire-FirstCall/ -- Wyeth (NYSE:WYE) is providing a $1 million cash donation to relief agencies, including the American Red Cross and The Children's Health Fund, that are leading the way in assisting those living in Louisiana, Mississippi, Alabama, and Florida who were affected by

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125606286186401372005-09-01T13:24:00.000-07:002005-09-01T13:24:46.196-07:00

GlaxoSmithKline Aids Hurricane Relief Efforts; One Million Dollars and Health Care Products Donated RESEARCH TRIANGLE PARK, N.C., Sept. 1 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) shares the nation's deep concern for residents and communities of the Gulf Coast region devastated by Hurricane Katrina. As an immediate demonstration of support, GlaxoSmithKline is donating one million

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125606020704776172005-09-01T13:20:00.000-07:002005-09-01T13:20:20.706-07:00

Advance Media Registration for BIO InvestorForum 2005 Now OpenThe Biotechnology Industry Organization (BIO) InvestorForum 2005, a national investor forum showcasing the leading growth companies in life sciences, is set to take place at The Palace Hotel in San Francisco, October 19-20, 2005.The event is a premier opportunity to network with industry executives and investors focused exclusively on

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125605933994725682005-09-01T13:18:00.001-07:002005-09-01T13:18:53.996-07:00

BD to Present at Bear Stearns 18th Annual Healthcare Conference FRANKLIN LAKES, N.J., Sept. 1 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical technology company, announced today that it would present at the Bear Stearns 18th Annual Healthcare Conference on Tuesday, September 13, 2005 at 8:30 a.m. (ET).The live webcast of BD's presentation can be accessed

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125605925637789342005-09-01T13:18:00.000-07:002005-09-01T13:18:45.640-07:00

HMS Holdings Corp. Announces Sale of Accordis NEW YORK, Sept. 1 /PRNewswire-FirstCall/ -- HMS Holdings Corp. (NASDAQ:HMSY) announced today that it had completed the sale of its wholly-owned subsidiary Accordis Inc. to Accordis Holding Corp., a New York-based private company, for $8 million consisting of cash and an interest-bearing five-year promissory note. The Company also entered into a

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125605617313698742005-09-01T13:13:00.000-07:002005-09-01T13:13:37.326-07:00

Angiotech Pharmaceuticals to participate in Thomas Weisel Healthcare Conference VANCOUVER, Sept. 1 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI)(NASDAQ:TSX:)(NASDAQ:ANP), is scheduled to participate in the Thomas Weisel Healthcare Tailwinds Conference.Dr. William Hunter, President and Chief Executive Officer of Angiotech, will be making a 30-minute presentation at the

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125605386102801192005-09-01T13:09:00.001-07:002005-09-01T13:09:46.103-07:00

Thomas Weisel Partners Healthcare Tailwinds Conference 2005 to Webcast Millennium Presentation CAMBRIDGE, Mass., Sept. 1 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (NASDAQ:MLNM) today announced that its presentation at the Thomas Weisel Partners Healthcare Tailwinds Conference 2005 will be webcast live and may be accessed by visiting the Investors section of the Company's website,

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125605370183117772005-09-01T13:09:00.000-07:002005-09-01T13:09:30.196-07:00

Kensey Nash Announces Appointment of Walter R. Maupay, Jr. to Position of Non-Executive Board Chairman EXTON, Pa., Sept. 1 /PRNewswire-FirstCall/ -- Kensey Nash (NASDAQ:KNSY) today announced the appointment of Walter R. Maupay, Jr. to the position of chairman of the Board of Directors. Mr. Maupay has served on the Kensey Nash Board since June of 1995 and is currently a member of the Company's

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125602169638848042005-09-01T12:16:00.000-07:002005-09-01T12:16:09.653-07:00

Carrington Actively Coordinating Mouthwash Recall and Investigation With FDA and Texas Department of Health- Product Accounts for Less Than One Percent of Year-to-Date Revenue - Product Passed Industry-Standard Microbial Testing at Time of Release IRVING, Texas, Sept. 1 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (NASDAQ:CARN) previously initiated a voluntary recall of alcohol-free

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125599445248001242005-09-01T11:30:00.000-07:002005-09-01T11:30:45.270-07:00

Boston Scientific to Participate in Thomas Weisel Partners Healthcare Conference Natick, Mass., Sept. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the 2005 Thomas Weisel Partners Healthcare Conference, which is being held September 7 - 9 in Boston.Larry Best, Boston Scientific Executive Vice President for Finance and Administration and Chief

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125598557483382732005-09-01T11:15:00.000-07:002005-09-01T11:15:57.496-07:00

Emisphere Technologies Presentation at the Oppenheimer Diabetes Conference to be Webcast TARRYTOWN, N.Y., Sept. 1 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (NASDAQ:EMIS), today announced that it will participate in the Oppenheimer Diabetes Conference, being held at the Warwick Hotel in New York, NY. Michael M. Goldberg, M.D., Chairman and Chief Executive Officer, will present on

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125598439719275162005-09-01T11:13:00.000-07:002005-09-01T11:13:59.720-07:00

GenoMed Offers New Orleans Free Medical Assistance for Acute Kidney Failure and Mosquito-borne Viral Diseases like West Nile ST. LOUIS, Sept. 1 /PRNewswire-FirstCall/ -- GenoMed, Inc. ("the Company" or "GenoMed") (Pink Sheets: GMED) a St. Louis, Missouri-based Next Generation Disease Management company, announced today that it was offering free assistance to medical workers confronting acute

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125597926997626922005-09-01T11:05:00.000-07:002005-09-01T11:05:27.020-07:00

Defense Logistics Agency Supports Katrina Relief Efforts FORT BELVOIR, Va., Sept. 1 /PRNewswire/ -- The Defense Logistics Agency has increased support to provide commodities needed for Hurricane Katrina relief efforts. In conjunction with federal agencies including the Federal Emergency Management Agency and the Defense Department, DLA has augmented efforts to ensure that supplies are available

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125596528237949642005-09-01T10:42:00.000-07:002005-09-01T10:42:08.250-07:00

Why Customer Service Creates Industry Leaders and Losers CHAPEL HILL, N.C., Sept. 1 /PRNewswire/ -- Many successful companies started with an entrepreneur's dream of providing outstanding customer service. These companies quickly surpassed their competition due to a loyal customer base that valued their service experience. While the first names that come to mind may be the crème de la crème, like

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125595553466302712005-09-01T10:25:00.001-07:002005-09-01T10:25:53.480-07:00

Second Annual Exposition and Conference for Orthopaedic Industry OEMs to be Held in Chicago in 2006Thursday September 1 CHAGRIN FALLS, Ohio, Sept. 1 /PRNewswire/ -- Knowledge Enterprises, Inc. today announced the launch of OMTEC 2006, the Second Annual Orthopaedic Manufacturing & Technology Exposition and Conference for the orthopaedic industry's outsourcing decision makers.The event will be held

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125595547747042432005-09-01T10:25:00.000-07:002005-09-01T10:25:47.760-07:00

AstraZeneca Pledges More Than $1 Million in Contributions and Medicine to Victims of Hurricane Katrina WILMINGTON, Del., Sept. 1 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE:AZN), one of the world's leading pharmaceutical companies, today announced it will provide a direct cash contribution of $1 million to the American Red Cross to assist in Hurricane Katrina relief efforts. In addition, the

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125595241796141952005-09-01T10:20:00.000-07:002005-09-01T10:20:41.810-07:00

Advanced Life Sciences Announces Elections of Richard Reck and Scott Meadow to Its Board of Directors WOODRIDGE, Ill., Sept. 1 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (NASDAQ:ADLS) today announced the appointments of Richard Reck and Scott Meadow to its board of directors. Richard Reck is the founder and President of Business Strategy Advisors, and is a licensed Certified

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125594875071582662005-09-01T10:14:00.000-07:002005-09-01T10:14:35.083-07:00

Domantis Successful in Patent Opposition Proceedings-- Scope of Patent Coverage For Ablynx Dramatically Narrowed -- CAMBRIDGE, U.K. and CAMBRIDGE, Mass., Sept. 1 /PRNewswire/ -- Domantis Limited, the human Domain Antibody Therapeutics company, has successfully opposed European patent number EP0656946, leading to a major amendment of the main claim in the patent and a significant narrowing of the

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125594562560369782005-09-01T10:09:00.000-07:002005-09-01T10:09:22.576-07:00

AmeriCares Responds to Hurricane Katrina- Emergency Response Teams In Mississippi - STAMFORD, Conn., Sept. 1 /PRNewswire/ -- Two AmeriCares emergency relief teams are in Jackson, Mississippi and are preparing to receive AmeriCares relief shipments within the next few days."The situation here remains critical," said emergency relief worker Kathleen Oldaker. "Many people have been displaced from

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125593502363175992005-09-01T09:51:00.000-07:002005-09-01T09:51:42.380-07:00

CIGNA Provides Grant to Alex's Lemonade Stand in Support of Education, Research for Childhood Cancer'Power Of Caring' Ad Began National Groundswell of Support for Charity Devoted to Curing Childhood Cancer 'One Cup at a Time' PHILADELPHIA, Sept. 1, 2005 /PRNewswire-FirstCall/ -- In recognition of September as Childhood Cancer Awareness Month, the CIGNA Foundation today awarded a grant of $25,000

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125592903043214532005-09-01T09:41:00.000-07:002005-09-01T09:41:43.056-07:00

Par Pharmaceutical's Partner Receives Final Approval To Market Mirtazapine Orally Disintegrating TabletsUnder Licensing Agreement, Amide Pharmaceutical Will Market Generic Version of Remeron SolTab(R) SPRING VALLEY, N.Y., Sept. 1 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that its licensing partner, Amide Pharmaceutical, Inc., has received final

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125590549427891032005-09-01T09:02:00.000-07:002005-09-01T09:02:29.440-07:00

Cypher(R) Sirolimus-Eluting Coronary Stent Data to Be Presented at 2005 European Society of Cardiology Congress MIAMI, Sept. 1 /PRNewswire/ -- A broad range of clinical data on the use of the CYPHER(R) Sirolimus-eluting Coronary Stent will be presented at the 2005 European Society of Cardiology Congress (ESC 2005) taking place September 3 - 7 in Stockholm, Sweden. Several of the studies presented

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125589470663588132005-09-01T08:44:00.000-07:002005-09-01T08:44:30.666-07:00

ANSYS Announces Latest Releases of AQWA and ASAS Software SuitesLatest software addresses engineering issues in the marine and offshore industries SOUTHPOINTE, Pa., Sept. 1 /PRNewswire-FirstCall/ -- ANSYS, Inc. (NASDAQ:ANSS), a global innovator of simulation software and technologies designed to optimize product development processes, today announced the newest availability of ASAS(TM) 14,

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125589051184660982005-09-01T08:37:00.000-07:002005-09-01T08:37:31.186-07:00

Utah Medical Products, Inc.: FDA Trial Rescheduled SALT LAKE CITY, Sept. 1 /PRNewswire-FirstCall/ -- On August 31, 2005, the U.S. District Court in Salt Lake City expeditiously rescheduled the beginning date for the trial of the lawsuit filed in August 2004 on behalf of the U.S. Food and Drug Administration (FDA) alleging Quality System Regulation (QSR) violations by Utah Medical Products, Inc. (

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125588727948974012005-09-01T08:32:00.000-07:002005-09-01T08:32:07.960-07:00

PA Governor Rendell Announces GlaxoSmithKline Acquisition of Pennsylvania Vaccine Manufacturing FacilityPharmaceutical and Healthcare Company will Develop New Technology for Flu Vaccines, Create Nearly 300 Jobs and Invest at least $100 Million in Lancaster County HARRISBURG, Pa., Sept. 1 /PRNewswire/ -- PA Governor Edward G. Rendell today announced that GlaxoSmithKline (GSK) has acquired the

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125588392635866492005-09-01T08:26:00.000-07:002005-09-01T08:26:32.650-07:00

Hurricane Damage Has Lasting Effect: Hospice Offers Insight ALEXANDRIA, Va., Sept. 1 /PRNewswire/ -- The destruction caused by Hurricane Katrina and its aftermath is overwhelming. The National Hospice and Palliative Care Organization, a nonprofit group working on behalf of hospice providers across the nation, offers insight into the magnitude of reactions being felt across the country.Survivors

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125587373552507652005-09-01T08:09:00.000-07:002005-09-01T08:09:33.553-07:00

CFIF Blasts Lockyer's French Fry LawsuitStatement of Marshall Manson, CFIF VP of Public Affairs ALEXANDRIA, Va., Sept. 1 /PRNewswire/ -- In a lawsuit filed last Friday, California Attorney General Bill Lockyer asked a court to order several food companies to put warning labels on certain food products, including French Fries, that might contain the chemical acrylamide, which Lockyer claims might

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125586968944560602005-09-01T08:02:00.000-07:002005-09-01T08:02:48.960-07:00

The Burnham Institute Hosts Fourth Annual Gala Dinner to Benefit Arthritis ResearchTitled 'Under the Sea,' This Year's Gala Title Sponsored by Invitrogen Corporation SAN DIEGO, Sept. 1 /PRNewswire/ -- The Burnham Institute and title sponsor Invitrogen Corporation proudly present "Under the Sea," a gala dinner scheduled for Saturday, October 8, 2005. The proceeds of this event will benefit

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125586205581486222005-09-01T07:50:00.000-07:002005-09-01T07:50:05.583-07:00

Wyeth Sells its Marietta, Pennsylvania Manufacturing Facility to GlaxoSmithKline MADISON, N.J., Sept. 1 /PRNewswire-FirstCall/ -- Wyeth (NYSE:WYE) announced today the sale of its former Marietta, Pennsylvania vaccines manufacturing facility to GlaxoSmithKline. Wyeth discontinued operations at the facility as of December 31, 2004.Under the terms of the purchase agreement, Wyeth received an

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125586189319874752005-09-01T07:49:00.000-07:002005-09-01T07:49:49.333-07:00

GenoMed Scores 13th Victory Treating Neuroinvasive West Nile Virus in Humans ST. LOUIS, Sept. 1 /PRNewswire-FirstCall/ -- GenoMed Inc., ("the Company" or "GenoMed") (Pink Sheets: GMED) a St. Louis, Missouri-based Next Generation Disease Management company, announced today that it successfully treated its thirteenth patient with presumed West Nile virus encephalitis.The patient is a previously

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125585747750417252005-09-01T07:42:00.000-07:002005-09-01T07:42:27.760-07:00

MichBio Expo 2005 Announces Premier, Gold and Silver Sponsors ANN ARBOR, Mich., Sept. 1 /PRNewswire/ -- The MichBio Expo 2005 announced today that Pfizer Research and Development and the Michigan Economic Development Corporation are the premier sponsors for this year's 5th annual expo.Henry Ford Health System, Michigan State University, University of Michigan, and Wayne State University are the

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125584467401933912005-09-01T07:21:00.000-07:002005-09-01T07:21:07.423-07:00

Third Wave Wins Patent Infringement Suit Against Stratagene and Its FullVelocity Products MADISON, Wis., Sept. 1 /PRNewswire-FirstCall/ -- Third Wave Technologies Inc. (NASDAQ:TWTI) today announced that a federal jury has found Stratagene Corp. guilty of infringing patents that protect Third Wave's nucleic acid chemistry.Third Wave in September 2004 filed suit against Stratagene in U.S. District

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125583717545813522005-09-01T07:08:00.000-07:002005-09-01T07:08:37.560-07:00

Kinematic and ChemAxon Announce Strategic Partnership and Successful Implementation of Cheminformatics Capabilities Into eNovatorBUDAPEST, Hungary, SAN DIEGO, California and CORK, Ireland, September 1/PRNewswire/ -- KineMatik Ltd. and ChemAxon Ltd, announce a new strategicpartnership under which ChemAxon's Java based chemistry components have beenimplemented within KineMatik's flagship

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125583643192186832005-09-01T07:07:00.000-07:002005-09-01T07:07:23.193-07:00

YMC Co., Ltd Receives a 2005 Eli Lilly Global Supplier Award KYOTO, Japan, Sept. 1 /PRNewswire/ -- YMC Co., Ltd of Kyoto, Japan has received a 2005 Global Supplier Award from Eli Lilly and Company, Indianapolis, Indiana USA. The award is given to those companies who help Lilly create and sustain competitive advantage in the pharmaceutical marketplace.YMC is a manufacturer of bulk chromatographic

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125583409913977592005-09-01T07:03:00.000-07:002005-09-01T07:03:29.926-07:00

La Cardiopatía es el Asesino Número Uno Para los Hispanos Viviendo en EE.UU. y el Colesterol es un Serio Factor de RiesgoDietista Registrada dice que el cambio en estilo de vida es fundamental para reducir el colesterol en forma segura y naturalNORTHRIDGE, Calif., 1 de septiembre /PR Newswire/ -- La cardiopatía es el número uno asesino de Hispanos en los EE.UU. (1), y muchos no saben que sus

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125583289589579242005-09-01T07:01:00.000-07:002005-09-01T07:01:29.633-07:00

STERIS to Present at Thomas Weisel Partners' Healthcare Tailwinds Conference MENTOR, Ohio, Sept. 1 /PRNewswire-FirstCall/ -- STERIS Corporation (NYSE:STE) today announced that the Company will be presenting at Thomas Weisel Partners' Healthcare Tailwinds Conference in Boston on Thursday, September 8, 2005. Laurie Brlas, STERIS's senior vice president and chief financial officer, will begin the

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125582034135527602005-09-01T06:40:00.000-07:002005-09-01T06:40:34.150-07:00

DrugMax Comments on Effect of Hurricane Katrina FARMINGTON, Conn., Sept. 1 /PRNewswire-FirstCall/ -- DrugMax, Inc. (NASDAQ:DMAX), a specialty pharmacy and drug distribution provider, announced today that the Company's St. Rose, Louisiana distribution facility has been closed due to Hurricane Katrina. As part of DrugMax's emergency response plan, it shifted operations from its New Orleans

jenenoreply@blogger.comtag:blogger.com,1999:blog-15616485.post-1125581625963615792005-09-01T06:33:00.000-07:002005-09-01T06:33:45.966-07:00

Altachem Pharma Ltd. Receives Health Canada Clearance to Initiate Phase I clinical trial for Actinic Keratosis- Company moves into clinical phase with 'Sonolight' Technology -Trading Symbol: AAF:TSX Venture Exchange EDMONTON, Sept. 1 /PRNewswire-FirstCall/ -- Altachem Pharma Ltd. ("Altachem" or "the Company") announced today that it has received clearance from the Therapeutic Products Directorate

jenenoreply@blogger.com